Biopharmaceutical Manufacturing, Upstream, Downstream processing news

Headlines

Pfizer/BioNTech COVID-19 vaccine is safe for elderly people, says WHO

The World Health Organization’s Global Advisory Committee on Vaccine Safety says it has not seen any unexpected or untoward increase in fatalities in frail and elderly individuals who have received the Pfizer/BioNTech vaccine.

Oxford University weighing up how vaccine platform would need to adapt to deal with variants

The team behind the Oxford-AstraZeneca COVID-19 vaccine says it is carefully assessing the impact of new variants from the UK, South Africa and Brazil on vaccine immunity.

GSK sells vaccine laboratory activities to Nexelis

GSK has sold its GCLP-certified clinical bioanalytical laboratory located in Marburg, Germany to Canadian clinical research organization (CRO), Nexelis.

Pfizer/BioNTech ‘encouraged’ by new data on vaccine effectiveness against UK strain

Pfizer and BioNTech have re-iterated that their COVID-19 vaccine appears to be effective against the UK strain, with the publication of new data today.

No strings attached: COVID-19 pandemic raises profile of non-dilutive funding for life science companies

US government non-dilutive funding has played a key role in the accelerated development of the COVID-19 vaccine.

VBI Vaccines to begin Phase 1/2 study of coronavirus vaccine candidate

VBI Vaccines is due to start a Phase 1/2 study of a coronavirus vaccine candidate in Q1 2021, after a preclinical hamster challenge study demonstrated ‘robust immunogenicity and efficacy’.